Information Provided By: 
Fly News Breaks for July 12, 2016
HTA
Jul 12, 2016 | 07:34 EDT
Oppenheimer analyst Steve Manaker raised his price target for Healthcare Trust to $37 from $32, saying the REIT offers a combination of steady internal growth and disciplined external growth, all on an active management platform. While the analyst acknowledges that the company's stock isn't cheap, Manaker says he continues to favor the "disciplined, steady growers" like Healthcare Trust. Oppenheimer has an Outperform rating on the shares.
News For HTA From the Last 2 Days
There are no results for your query HTA
